Search results
Results from the WOW.Com Content Network
The company was founded by Colonel Eli Lilly, a pharmaceutical chemist and Union Army veteran of the American Civil War. Lilly served as the company president until his death in 1898. [20] In 1869, after working for drugstores in Indiana, Lilly became a partner in a Paris, Illinois-based drugstore with James W. Binford. [21]
Eli Lilly (July 8, 1838 – June 6, 1898) was a Union Army officer, pharmacist, chemist, and businessman who founded Eli Lilly and Company. Lilly enlisted in the Union Army during the American Civil War and recruited a company of men to serve with him in the 18th Independent Battery Indiana Light Artillery .
Lilly was born on April 1, 1885, in Indianapolis, the eldest son of Josiah K. Lilly Sr. and Lilly Maria Ridgely Lilly. [2] He was named for his grandfather, Colonel Eli Lilly, who founded Eli Lilly and Company, the family's pharmaceutical business in Indianapolis. [3]
Her great-grandfather, Colonel Eli Lilly, founded Eli Lilly and Company in 1876. Her grandfather, Josiah K. Lilly Sr., succeeded Colonel Lilly as president of the pharmaceutical company in 1898 and became chairman of the board in 1932. Her father, Josiah K. Lilly Jr., joined the family firm in 1914 and served as its president (1948–53) and ...
Founded in 1876, Eli Lilly and Co. was founded with the goal of creating real medicines that would compete with elixirs that did little for patients. In the years that followed, it developed into ...
Josiah Kirby Lilly Sr. (November 18, 1861 – February 8, 1948), nicknamed "J. K.," was an American businessman, pharmaceutical industrialist, and philanthropist who became president and chairman of the board of Eli Lilly and Company, the pharmaceutical firm his father, Colonel Eli Lilly, founded in 1876.
Mounjaro was Eli Lilly's best-selling drug in the second quarter with sales of $3.09 billion, a more than threefold increase compared to a year ago. Zebound, meanwhile, was the company's fourth ...
During Q3, Eli Lilly brought in $11.4 billion in sales, up 20% from a year prior, and non-GAAP (adjusted) EPS of $1.18, which was $0.29 less than what the average of Wall Street analysts had ...